Publicacións en colaboración con investigadores/as de Universidad CEU San Pablo (11)

2018

  1. Aligning digital CD8 + scoring and targeted next-generation sequencing with programmed death ligand 1 expression: a pragmatic approach in early-stage squamous cell lung carcinoma

    Histopathology, Vol. 72, Núm. 2, pp. 270-284

2016

  1. Profile of Ventana ALK (D5F3) companion diagnostic assay for non-small-cell lung carcinomas

    Expert Review of Molecular Diagnostics, Vol. 16, Núm. 6, pp. 707-713

2015

  1. The anaplastic lymphoma kinase testing conundrum

    Expert Review of Molecular Diagnostics, Vol. 15, Núm. 2, pp. 161-163

2013

  1. Lung adenocarcinoma in the era of targeted therapies: Histological classification, sample prioritization, and predictive biomarkers

    Clinical and Translational Oncology, Vol. 15, Núm. 7, pp. 503-508

  2. The ALK translocation in advanced non-small-cell lung carcinomas: Preapproval testing experience at a single cancer centre

    Histopathology, Vol. 62, Núm. 4, pp. 609-616

2012

  1. A comparison of EGFR mutation testing methods in lung carcinoma: Direct sequencing, real-time PCR and immunohistochemistry

    PLoS ONE, Vol. 7, Núm. 8

  2. Chromophobe renal cell carcinoma: A review of an uncommon entity

    International Journal of Urology, Vol. 19, Núm. 10, pp. 894-900

  3. Tumor fibroso solitario del hilio renal: un diagnóstico poco común de un cuadro clínico no tan raro

    Actas Urologicas Espanolas

2011

  1. Hybridization for human epidermal growth factor receptor 2 testing in gastric carcinoma: A comparison of fluorescence in-situ hybridization with a novel fully automated dual-colour silver in-situ hybridization method

    Histopathology, Vol. 59, Núm. 1, pp. 8-17

2010

  1. A commercial real-time PCR kit provides greater sensitivity than direct sequencing to detect KRAS mutations: A morphology-based approach in colorectal carcinoma

    Journal of Molecular Diagnostics, Vol. 12, Núm. 3, pp. 292-299

  2. The use of P63 immunohistochemistry for the identification of squamous cell carcinoma of the lung

    PLoS ONE, Vol. 5, Núm. 8